Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 1/20 | 0.63 |
| ▸ | PTGES | O14684 | 1/20 | 0.61 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.61 |
| ▸ | SLC10A1 | Q14973 | 2/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.59 |
| ▸ | NT5E | P21589 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | TOP2A | P11388 | 1/20 | 0.59 |
| ▸ | RELA | Q04206 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 4/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5800555 | 0.98 | CETP (0.61) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| SCHEMBL14388723 | 0.95 | CETP (0.69) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| SCHEMBL5798459 | 0.95 | CETP (0.69) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| SCHEMBL14110309 | 0.95 | CETP (0.69) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| SCHEMBL2257652 | 0.95 | CETP (0.69) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| SCHEMBL14191491 | 0.93 | CETP (0.71) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| SCHEMBL14108321 | 0.89 | CETP (0.68) | CETPPTGESPRKCDSLC10A1PTPN1 | |
| Lupeol Linoleate SCHEMBL935903 | 0.88 | CETP (0.61) | CETPPTGESPRKCDPTPN1NT5E | |
| Lupeol Linoleate SCHEMBL935900 | 0.88 | CETP (0.61) | CETPPTGESPRKCDPTPN1NT5E | |
| SCHEMBL1867184 | 0.88 | CETP (0.81) | CETPPTGESPRKCDSLC10A1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006050158-A2 | HAIR AND SKIN PROTECTING COMPOSITIONS BASED ON ESTERS OR ETHERS OF BETULIN | GLINSKI JAN (US) | 2006-05-11 | — | — | WO | disclosed |
| US-20060093571-A1 | Hair and skin protecting compositions based on esters or ethers of betulin | GLINSKI JAN | 2006-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060093571-A1 | Hair and skin protecting compositions based on esters or ethers of betulin | BET1, CUTA, EBP | CETP 93/4885PTGES 289/4885PRKCD 2371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.